MW Brooklyn ImmunoTherapeutic changing name to Eterna Therapeutics on Monday
Brooklyn ImmunoTherapeutics Inc. $(BTX)$ said Tuesday it'll change its stock trading ticker to ERNA on Monday, Oct. 17, as part of a name change to Eterna Therapeutics Inc. The San Diego-based clinical stage biopharmaceutical company said the new name reflects its focus on developing advanced therapies using its patented mRNA cell engineering technologies. Shares of Brooklyn ImmunoTherapeutics rose 0.9% in premarket trades.
-
(END) Dow Jones Newswires
October 11, 2022 08:50 ET (12:50 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments